Windward Bio Group AG has recently filed a Form 3 with the SEC, indicating a change in ownership by director Sandip Kapadia. This filing, dated November 12, 2026, is significant as it reflects the company's current status and activities in the biological products industry.
Windward Bio Group AG, classified under the SIC code 2836, specializes in biological products, excluding diagnostic substances. The company is publicly traded under the ticker symbol WWB. The recent filing comes on the heels of multiple other filings, indicating an active period for the company.
The filing states that Sandip Kapadia is a director of Windward Bio Group AG, and he has reported ownership of one security. This information is essential for investors and stakeholders monitoring changes in the company’s leadership and ownership structure.
The impact of this filing may affect shareholders and potential investors who are interested in the company's governance and strategic direction. Changes in ownership can often lead to shifts in company policy or focus, particularly in a competitive industry like biological products.
As for what’s next, the filing does not specify any further actions or upcoming events related to this ownership change. Stakeholders will likely be watching for additional filings or announcements from the company in the near future.
Read Next
Clark Kyle Sells 15,000 Shares of Beta Technologies Stock
Ronald R. Taylor resigns as director of ResMed Inc.
Afsari Nasym acquires 68,235 shares of Onterris, Inc.
Onterris, Inc. Chief Strategy Officer Acquires Shares
StubHub Holdings' Mark Streams Sells 76,891 Shares
Francesca M. Edwardson Transfers 25,000 Shares to Trust




